Small intestinal function in neoplastic disease.

PubWeight™: 0.99‹?› | Rank: Top 15%

🔗 View Article (PMC 2008042)

Published in Br J Cancer on September 01, 1967

Authors

I W Dymock, N MacKay, V Miller, T J Thomson, B Gray, E H Kennedy, J F Adams

Articles by these authors

Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group. Lancet (1998) 7.53

Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group. J Clin Oncol (2000) 6.88

A rapid method for simultaneous detection of phenotypic resistance to inhibitors of protease and reverse transcriptase in recombinant human immunodeficiency virus type 1 isolates from patients treated with antiretroviral drugs. Antimicrob Agents Chemother (1998) 5.64

Carbenoxolone sodium in the treatment of gastric ulcer with special reference to side-effects. Gut (1965) 4.56

The relation between baseline HIV drug resistance and response to antiretroviral therapy: re-analysis of retrospective and prospective studies using a standardized data analysis plan. Antivir Ther (2000) 3.14

HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load. JAMA (2001) 2.95

Global experience in cervical carotid artery stent placement. Catheter Cardiovasc Interv (2000) 2.77

Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy. Blood (2001) 2.37

Treatment of obesity by total fasting for up to 249 days. Lancet (1966) 2.31

Detection of inflammatory bowel disease in adults and children: evaluation of a new isotopic technique. Br Med J (Clin Res Ed) (1985) 2.30

Phenotypic and genotypic analysis of clinical HIV-1 isolates reveals extensive protease inhibitor cross-resistance: a survey of over 6000 samples. AIDS (2000) 2.15

Arteriohepatic dysplasia: familial pulmonary arterial stenosis with neonatal liver disease. Arch Dis Child (1973) 2.11

Arthropathy of haemochromatosis. Clinical and radiological analysis of 63 patients with iron overload. Ann Rheum Dis (1970) 2.09

A family of insertion mutations between codons 67 and 70 of human immunodeficiency virus type 1 reverse transcriptase confer multinucleoside analog resistance. Antimicrob Agents Chemother (1999) 2.08

Asymptomatic liver disease in hepatitis B antigen carriers. J Clin Pathol (1974) 2.00

Prolonged starvation--a dangerous procedure? Br Med J (1970) 1.90

Rehabilitation after anterior cruciate ligament reconstruction: a systematic review. J Bone Joint Surg Am (2012) 1.89

Clinical trial of deglycyrrhizinized liquorice in gastric ulcer. Gut (1969) 1.88

Difference in structure between type b and nontypable Haemophilus influenzae populations. Infect Immun (1986) 1.84

A novel human immunodeficiency virus type 1 reverse transcriptase mutational pattern confers phenotypic lamivudine resistance in the absence of mutation 184V. Antimicrob Agents Chemother (2000) 1.75

Modification of the Fe Protein of Nitrogenase in Natural Populations of Trichodesmium thiebautii. Appl Environ Microbiol (1993) 1.75

World-wide variation in HIV-1 phenotypic susceptibility in untreated individuals: biologically relevant values for resistance testing. AIDS (2001) 1.73

Progestins and breast cancer: an epidemiologic review. Fertil Steril (1992) 1.71

Outbreak of infantile gastro-enteritis caused by Escherichia coli O114. Arch Dis Child (1970) 1.71

The effect of diet on ileostomy function. Gut (1970) 1.65

Immunity to cross-reactive serotypes induced by pneumococcal conjugate vaccines in infants. J Infect Dis (1999) 1.63

Long term benefits of hypnotherapy for irritable bowel syndrome. Gut (2003) 1.63

Quality of life in inflammatory bowel disease: a cross-cultural comparison of English and Canadian children. J Pediatr Gastroenterol Nutr (2001) 1.57

A biochemically distinct form of cytochrome oxidase (COX) deficiency in the Saguenay-Lac-Saint-Jean region of Quebec. Am J Hum Genet (1993) 1.57

The prevalence and characteristics of battered women in a primary care setting. Nurse Pract (1989) 1.53

A broader vision for managed care, Part 1: Measuring the benefit to communities. Health Aff (Millwood) (1998) 1.51

The effect of metoclopramide on gastric emptying of solid meals. Gut (1974) 1.46

Successful treatment of gemcitabine toxicity with a brief course of oral corticosteroid therapy. Chest (1998) 1.45

Epilepsy and Crohn's disease in children. J Pediatr Gastroenterol Nutr (1998) 1.44

The influence of topical anaesthetic agent at bronchoalveolar lavage upon cellular yield and identification and upon macrophage function. Br J Dis Chest (1986) 1.44

The differential ferrioxamine test in the management of idiopathic haemochromatosis. Lancet (1969) 1.43

Maternal smoking and medical expenditures for childhood respiratory illness. Am J Public Health (1997) 1.42

After hours medical services. N Z Med J (1996) 1.40

Induction and prevention of colonic inflammation in IL-2-deficient mice. J Immunol (1997) 1.40

Coagulation studies as a prognostic index in acute liver failure. Br J Haematol (1975) 1.39

Out of hospital cardiac arrest. N Z Med J (1996) 1.39

Abnormal fibrin polymerization in liver disease. Br J Haematol (1976) 1.39

Screening for problem drinking and counseling by the primary care physician-nurse team. Alcohol Clin Exp Res (1996) 1.38

Use of cisapride in treatment of constipation in children. J Pediatr Gastroenterol Nutr (1997) 1.38

Ascorbic acid supplementation in the treatment of pressure-sores. Lancet (1974) 1.35

Hypoglycemic activity of endotoxin. II. Mechanism of the phenomenon in BCG-infected mice. J Bacteriol (1969) 1.34

Simple clinical method of measuring gastric emptying of solid meals. Gut (1976) 1.33

Determinants of sustainable CD4 lymphocyte count increases in response to antiretroviral therapy. AIDS (1999) 1.33

Isolation of a full-length complementary DNA coding for human E1 alpha subunit of the pyruvate dehydrogenase complex. J Biol Chem (1988) 1.33

e Antigen-antibody system as indicator of liver damage in patients with hepatitis-B antigen. Br Med J (1975) 1.32

Atrophy of the lateral geniculate nucleus in human glaucoma detected by magnetic resonance imaging. Br J Ophthalmol (2008) 1.29

Use of clindamycin disks To detect macrolide resistance mediated by ermB and mefE in Streptococcus pneumoniae isolates from adults and children. J Clin Microbiol (2000) 1.29

Assessing for abuse: self-report versus nurse interview. Public Health Nurs (1991) 1.28

Updated European recommendations for the clinical use of HIV drug resistance testing. Antivir Ther (2004) 1.28

Zollinger-Ellison syndrome type 1: clinical and pathological correlations in a case. Gut (1973) 1.27

Treatment of non-cardiac chest pain: a controlled trial of hypnotherapy. Gut (2006) 1.26

Myocarditis associated with psittacosis. Br J Clin Pract (1971) 1.25

Assessment of regional cerebral perfusion by 99Tcm-HMPAO SPECT in chronic fatigue syndrome. Nucl Med Commun (1992) 1.23

Liver disease in patients with joint symptoms. Ann Rheum Dis (1974) 1.23

A novel syndrome affecting multiple mitochondrial functions, located by microcell-mediated transfer to chromosome 2p14-2p13. Am J Hum Genet (2001) 1.22

Observations on the pathogenesis, complications and treatment of diabetes in 115 cases of haemochromatosis. Am J Med (1972) 1.21

Percutaneous AngioJet thrombectomy in the management of extensive deep venous thrombosis. J Vasc Interv Radiol (2001) 1.21

Age distribution of lymphocytic choriomeningitis virus serum antibody in Birmingham, Alabama: evidence of a decreased risk of infection. Am J Trop Med Hyg (1997) 1.20

Antiviral activity of tenofovir (PMPA) against nucleoside-resistant clinical HIV samples. Nucleosides Nucleotides Nucleic Acids (2001) 1.19

Time-course of formation of volatile reductive metabolites of halothane in humans and an animal model. Br J Anaesth (1980) 1.19

A protective monoclonal antibody that reacts with a novel antigen of pneumococcal teichoic acid. Microb Pathog (1987) 1.18

The hypoglycemic activity of endotoxin. I. Occurrence in animals hyperreactive to endotoxin. Proc Soc Exp Biol Med (1969) 1.17

Laboratory guidelines for the practical use of HIV drug resistance tests in patient follow-up. Antivir Ther (2001) 1.14

Impact of the WIC program on the iron status of infants. Pediatrics (1985) 1.12

Complications associated with the use of urokinase and recombinant tissue plasminogen activator for catheter-directed peripheral arterial and venous thrombolysis. J Vasc Interv Radiol (2000) 1.10

Improving evidence developed from population-level experience with targeted agents. Clin Pharmacol Ther (2015) 1.10

Gut-focused hypnotherapy normalizes disordered rectal sensitivity in patients with irritable bowel syndrome. Aliment Pharmacol Ther (2003) 1.10

Survival of transitional cell carcinoma cases in 2 Yorkshire centres. Br J Urol (1980) 1.09

Enteropathy in malignant disease. Br J Cancer (1966) 1.09

Chronic gastritis--a simple classification. J Pathol (1975) 1.09

Virological response to protease inhibitor therapy in an HIV clinic cohort. AIDS (1999) 1.09

Pulmonary alveolar proteinosis presenting with pneumothorax. Clin Radiol (1967) 1.08

Limitations of tetrazolium salts in delineating infarcted brain. Acta Neuropathol (1984) 1.08

Cell-mediated immunity to hepatitis B surface antigen in blood donors with persistent antigenaemia. Gut (1975) 1.08

Relationship of hepatic iron concentration to histochemical grading and to total chelatable body iron in conditions associated with iron overload. Gut (1971) 1.07

Total fasting, hyperuricaemia and gout. Postgrad Med J (1969) 1.07

Malabsorption of vitamin B12 and intrinsic factor secretion during biguanide therapy. Diabetologia (1983) 1.06

Angiotensin- and norepinephrine-induced myocardial lesions: experimental and clinical studies in rabbits and man. Am Heart J (1975) 1.05

Importance of epidemiology. Lancet (1983) 1.03

Naturally occurring antibodies to phosphocholine as a potential index of antibody responsiveness to polysaccharides. J Infect Dis (1987) 1.03

Isochromosome for long arm of Y chromosome in patient with Turner's syndrome and sex chromosome mosaicism (45,X-46,XYqi). J Med Genet (1969) 1.03

Occurrence and prevalence of diabetic retinopathy in hemochromatosis. Diabetes (1971) 1.03

The virological response to highly active antiretroviral therapy over the first 24 weeks of therapy according to the pre-therapy viral load and the weeks 4-8 viral load. AIDS (2001) 1.02

Hemodynamic evaluation of the aortoiliac system based on pharmacologic vasodilatation. Surgery (1983) 1.01

The influence of attitudes about unintended pregnancy on use of prenatal and postpartum care. J Perinatol (2000) 1.01

Developmental expression of a neuron-specific beta-tubulin in frog (Xenopus laevis): a marker for growing axons during the embryonic period. J Comp Neurol (1996) 1.00

Purine nucleoside phosphorylase deficiency associated with a fatal lymphoproliferative disorder. Arch Dis Child (1981) 1.00

Hepatotoxicity and halothane metabolism in an animal model with application for human toxicity. Anaesth Intensive Care (1979) 1.00

Denver Developmental Screening Test: cultural variations in Southeast Asian children. J Pediatr (1984) 1.00

Estimation of cumulative lead releases (lead flux) from the maternal skeleton during pregnancy and lactation. J Lab Clin Med (1999) 0.99

The use of and response to second-line protease inhibitor regimens: results from the EuroSIDA study. AIDS (2001) 0.99

Angelman syndrome: clinical profile. J Child Neurol (1992) 0.99

Ethylene chlorohydrin intoxication with fatality. Arch Dis Child (1970) 0.99

Nodular, non-cirrhotic liver associated with portal hypertension in a patient with rheumatoid arthritis. J Clin Pathol (1974) 0.99